1. Home
  2. BNBX vs SILO Comparison

BNBX vs SILO Comparison

Compare BNBX & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied DNA Sciences Inc.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$0.75

Market Cap

5.5M

ML Signal

N/A

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.31

Market Cap

4.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNBX
SILO
Founded
1983
2010
Country
Employees
N/A
N/A
Industry
Other Consumer Services
Apparel
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
4.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNBX
SILO
Price
$0.75
$0.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
81.3K
100.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$253.12
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.27
52 Week High
$128.55
$1.52

Technical Indicators

Market Signals
Indicator
BNBX
SILO
Relative Strength Index (RSI) 27.87 38.07
Support Level $0.74 $0.29
Resistance Level $0.90 $0.33
Average True Range (ATR) 0.16 0.03
MACD -0.01 -0.00
Stochastic Oscillator 8.97 25.30

Price Performance

Historical Comparison
BNBX
SILO

About BNBX Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: